Showing 2,021 - 2,040 results of 6,732 for search '(( significant based decrease ) OR ( significant ((shape decrease) OR (small decrease)) ))', query time: 0.54s Refine Results
  1. 2021

    Presentation 1_Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.pdf by Meiling Zhang (352540)

    Published 2024
    “…Background<p>Non-small cell lung cancer (NSCLC) with human epidermal growth factor receptor 2 (HER2) alterations poses a substantial treatment challenge. …”
  2. 2022
  3. 2023
  4. 2024
  5. 2025
  6. 2026
  7. 2027
  8. 2028
  9. 2029
  10. 2030
  11. 2031

    Data Sheet 1_Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-in... by Zhixue Fu (7540256)

    Published 2025
    “…Background<p>For unresectable stage III non-small cell lung cancer (NSCLC), the standard regimen is definitive concurrent chemoradiotherapy (CRT) followed by consolidation immunotherapy. …”
  12. 2032
  13. 2033

    Cox risk curve. by Zhendong Sun (4723221)

    Published 2025
    Subjects:
  14. 2034
  15. 2035
  16. 2036
  17. 2037
  18. 2038
  19. 2039
  20. 2040